Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Increasing Cases of Infectious Diseases
    3. Market Restraints
      1. High Cost of Advanced Diagnostic Technologies
      2. Lack of Skilled Professionals
    4. Market Opportunity
      1. Increasing Awareness About Food Safety Practices
    5. Market Trends
      1. Increased Adoption of Automation and AI in Microbial Identification
      2. Expansion of Next-Generation Sequencing (NGS) for Microbial Genomics
  5. MARKET SEGMENTATION
    1. By Product & Services
      1. Instruments
        1. Mass Spectrometers
        2. PCR Systems
        3. Microarrays
        4. Others
      2. Consumables
        1. Reagents & Kits
        2. Plates & Media
      3. Software & Services
        1. Identification Services
        2. Culture Collection Services
        3. Assay Validation Services
    2. By Technology
      1. Mass Spectrometry
      2. PCR
      3. Microarrays
      4. Next Generation Sequencing
      5. Others
    3. By Method
      1. Phenotypic Methods
      2. Genotypic Methods
      3. Proteotypic Methods
    4. By Application
      1. Clinical Diagnostics
      2. Pharmaceuticals
      3. Food & Beverage Testing
      4. Environmental Application
      5. Others
    5. By End-Use
      1. Pharmaceutical and Biotechnology Companies
      2. Hospitals and Diagnostic Laboratories
      3. Food Testing Laboratories
      4. Others
    6. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. bioMérieux SA
      2. Biolog Inc.
      3. Bruker Corporation
      4. Becton
      5. Charles River
      6. Danaher Corporation
      7. Dickinson and Company
      8. Eurofins Scientific SE
      9. Qiagen N.V.
      10. Merck KGaA
      11. Shimadzu Corporation
      12. Thermo Fisher Scientific Inc.
      13. VWR International LLC. (Avantor Inc.)
      14. Wickham Micro Limited
  7. MARKET OPPORTUNITIES AND FUTURE TREND



Frequently Asked Questions

Q.1. What is the projected market value of the global Microbial Identificationmarket?

The global market of Microbial Identification is projected to reach USD10.9Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Microbial Identificationmarket?

The global Microbial Identification market has an estimated annual growth rate of 11.8%.

Q.3. What are the recent trends of Microbial Identificationmarket?

Increased adoption of automation and AI in microbial identification and expansion of Next-Generation Sequencing (NGS) for microbial genomicsare some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in Microbial Identification?

The major companies profiled in this report include bioMérieux SA, Biolog Inc., Bruker Corporation, Becton, Charles River, Danaher Corporation, Dickinson and Company, Eurofins Scientific SE, Qiagen N.V., Merck KGaA, Shimadzu Corporation, Thermo Fisher Scientific Inc., VWR International LLC. (Avantor Inc.), Wickham Micro Limited, among others.   

Q.5. Which is the largest regional market in the Microbial Identification?

North America is the largest regional market for Microbial Identification.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.